BVVBY vs. MEDP

Last updated Apr 2, 2026

Compare and contrast key facts about Bureau Veritas SA (BVVBY) and Medpace Holdings, Inc. (MEDP).

Performance

BVVBY vs. MEDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bureau Veritas SA (BVVBY) and Medpace Holdings, Inc. (MEDP). The values are adjusted to include any dividend payments, if applicable.

BVVBY vs. MEDP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
BVVBY Bureau Veritas SA	-5.56%	9.04%	22.87%	-0.75%	-19.52%	4.83%
MEDP Medpace Holdings, Inc.	-12.85%	69.05%	8.38%	44.31%	-2.40%	18.57%

Fundamentals

Market Cap BVVBY : $13.40B MEDP : $14.18B
EPS BVVBY : $5.15 MEDP : $15.23
PE Ratio BVVBY : 11.68 MEDP : 32.13
PEG Ratio BVVBY : 1.42 MEDP : 0.97
PS Ratio BVVBY : 1.06 MEDP : 5.73
PB Ratio BVVBY : 7.84 MEDP : 30.88
Total Revenue (TTM) BVVBY : $12.78B MEDP : $2.53B
Gross Profit (TTM) BVVBY : $5.30B MEDP : $760.62M
EBITDA (TTM) BVVBY : $2.15B MEDP : $541.22M

Returns By Period

In the year-to-date period, BVVBY achieves a -5.56% return, which is significantly higher than MEDP's -12.85% return.

BVVBY

• 1D: 0.30%
• 1M: -12.52%
• YTD: -5.56%
• 6M: -4.90%
• 1Y: 3.58%
• 3Y*: 4.84%
• 5Y*: —
• 10Y*: —

MEDP

• 1D: 1.93%
• 1M: 7.00%
• YTD: -12.85%
• 6M: -10.01%
• 1Y: 64.40%
• 3Y*: 37.56%
• 5Y*: 23.60%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BVVBY vs. MEDP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BVVBY

BVVBY Risk / Return Rank: 42
BVVBY Sharpe Ratio Rank: 46
BVVBY Sortino Ratio Rank: 38
BVVBY Omega Ratio Rank: 37
BVVBY Calmar Ratio Rank: 44
BVVBY Martin Ratio Rank: 45

MEDP

MEDP Risk / Return Rank: 78
MEDP Sharpe Ratio Rank: 73
MEDP Sortino Ratio Rank: 83
MEDP Omega Ratio Rank: 84
MEDP Calmar Ratio Rank: 75
MEDP Martin Ratio Rank: 78

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BVVBY vs. MEDP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bureau Veritas SA (BVVBY) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BVVBY	MEDP	Difference
Sharpe ratio Return per unit of total volatility	0.18	0.96	-0.78
Sortino ratio Return per unit of downside risk	0.39	2.33	-1.95
Omega ratio Gain probability vs. loss probability	1.05	1.32	-0.28
Calmar ratio Return relative to maximum drawdown	0.17	1.84	-1.67
Martin ratio Return relative to average drawdown	0.43	5.41	-4.98
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BVVBY vs. MEDP - Sharpe Ratio Comparison

The current BVVBY Sharpe Ratio is 0.18, which is lower than the MEDP Sharpe Ratio of 0.96. The chart below compares the historical Sharpe Ratios of BVVBY and MEDP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BVVBY	MEDP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.18	0.96	-0.78
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.47	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.05	0.70	-0.65

Correlation

The correlation between BVVBY and MEDP is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BVVBY vs. MEDP - Dividend Comparison

BVVBY's dividend yield for the trailing twelve months is around 3.45%, while MEDP has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022
BVVBY Bureau Veritas SA	3.45%	3.26%	2.95%	3.31%	2.10%
MEDP Medpace Holdings, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

BVVBY vs. MEDP - Drawdown Comparison

The maximum BVVBY drawdown since its inception was -35.90%, smaller than the maximum MEDP drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for BVVBY and MEDP.

Drawdown Indicators

	BVVBY	MEDP	Difference
Max Drawdown Largest peak-to-trough decline	-35.90%	-42.87%	+6.97%
Max Drawdown (1Y) Largest decline over 1 year	-14.07%	-32.96%	+18.89%
Max Drawdown (5Y) Largest decline over 5 years	—	-42.87%	—
Current Drawdown Current decline from peak	-13.80%	-21.13%	+7.33%
Average Drawdown Average peak-to-trough decline	-12.87%	-12.64%	-0.23%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.77%	11.21%	-5.44%

Volatility

BVVBY vs. MEDP - Volatility Comparison

The current volatility for Bureau Veritas SA (BVVBY) is 5.05%, while Medpace Holdings, Inc. (MEDP) has a volatility of 11.03%. This indicates that BVVBY experiences smaller price fluctuations and is considered to be less risky than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BVVBY	MEDP	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.05%	11.03%	-5.98%
Volatility (6M) Calculated over the trailing 6-month period	14.14%	29.61%	-15.47%
Volatility (1Y) Calculated over the trailing 1-year period	20.47%	67.76%	-47.29%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.84%	50.91%	-27.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.84%	49.57%	-25.73%

Financials

BVVBY vs. MEDP - Profitability Comparison

The chart below illustrates the profitability comparison between Bureau Veritas SA and Medpace Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

BVVBY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Bureau Veritas SA reported a gross profit of 173.01M and revenue of 3.25B. Therefore, the gross margin over that period was 5.3%.

MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Medpace Holdings, Inc. reported a gross profit of 205.32M and revenue of 708.45M. Therefore, the gross margin over that period was 29.0%.

BVVBY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Bureau Veritas SA reported an operating income of 166.16M and revenue of 3.25B, resulting in an operating margin of 5.1%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Medpace Holdings, Inc. reported an operating income of 153.27M and revenue of 708.45M, resulting in an operating margin of 21.6%.

BVVBY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Bureau Veritas SA reported a net income of 263.73M and revenue of 3.25B, resulting in a net margin of 8.1%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Medpace Holdings, Inc. reported a net income of 135.13M and revenue of 708.45M, resulting in a net margin of 19.1%.